Functional impairment in fibrosing alveolitis: Relationship to reversible disease on thin section computed tomography

European Respiratory Journal

Volumn 10, Issue 2, 1997, Pages 280-285

  Wells, A U ^a,b   Rubens, M B ^a   Du Bois, R M ^a   Hansell, D M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b GREEN LANE HOSPITAL   (New Zealand)

Author keywords

computed tomography; fibrosing alveolitis; idiopathic pulmonary fibrosis; pulmonary function testing

Indexed keywords

CYCLOPHOSPHAMIDE; PENICILLAMINE; PREDNISOLONE;

ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FIBROSING ALVEOLITIS; HUMAN; IDIOPATHIC DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SMOKING;

FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG; MALE; MIDDLE AGED; OBSERVER VARIATION; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; RESPIRATORY MECHANICS; SCLERODERMA, SYSTEMIC; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031052080     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10020280     Document Type: Article

References (31)

1. Carrington CB, Gaensler EA, Coutu RE, Fitzgerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298: 801-809.
2. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35: 171-180.
3. Harrison NK, Myers R, Corrin B, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991; 144: 706-713.
4. Johnson MA, Kwan S, Snell NJC, Nunn AJ, Darbyshire JH, Turner-Warwick M. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low-dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 1989; 44: 280-288.
5. Raghu G, Depaso WJ, Cain K, et al. Azathioprine combined with prednisolone in the treatment of idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991; 144: 291-296.
6. Wells AU, Hansell DM, Rubens MB, Cullinan P, Black CM, du Bois RM. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis 1993; 148: 1076-1082.
7. Wells AU, Rubens MB, du Bois RM, Hansell DM. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. Am J Radiol 1993; 161: 1159-1165.
8. Fulmer JD, Roberts WC, von Gal ER, Crystal RG. Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J Clin Invest 1979; 63: 665-676.
9. Green GM, Graham WGB, Hanson JS, et al. Correlated studies of interstitial pulmonary disease. Chest 1976; 69 (Suppl.): 263-284.
10. Cherniack RM, Colby TV, Flint A, et al. Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 151: 1180-1188.
11. Chinet T, Jaubert F, Dusser D, Danel C, Chretien J, Huchon GJ. Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. Thorax 1990; 45: 675-678.
12. Collins CD, Wells AU, Morgan RA, et al. Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography. Clin Radiol 1994; 49: 236-240.
13. Mathieson JR, Mayo JR, Staples CA, Müller NL. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989; 171: 111-116.
14. Tung KT, Wells AU, Rubens MB, Kirk JME, du Bois RM, Hansell DM. Accuracy of typical computed tomography appearances of fibrosing alveolitis. Thorax 1993; 48: 334-338.
15. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
16. Müller NL, Staples CA, Miller RR, Vedal S, Thurlbeck WM, Ostrow DN. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 1987; 165: 731-734.
17. Wells AU, Hansell DM, Corrin B, et al. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992; 47: 738-742.
18. Müller NL, Miller RR, Webb WR, Evans KG, Ostrow DN. Fibrosing alveolitis: CT-pathologic correlation. Radiology 1986; 160: 585-588.
19. Nishimura K, Kitaichi M, Izumi T, Nagai S, Kanaoka M, Itoh H. Usual interstitial pneumonia: histologic correlation with high resolution CT. Radiology 1992; 182: 337-342.
20. Quanjer PH. Standardised lung function testing. Clin Respir Physiol 1983; 19 (Suppl.) 5: 1-95.
21. Riley RL, Cournand A. Ideal alveolar air and the analysis of ventilation-perfusion relationships in the lungs. J Appl Physiol 1949; 1: 825-847.
22. Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary Fibrosis. Am Rev Respir Dis 1986; 133: 97-103.
23. Chinn S. Statistics in respiratory medicine: repeatability and method comparison. Thorax 1991; 46: 454-456.
24. Fleiss JL. Statistical methods for rates and proportions. New York, NY, Wiley, 1973.
25. Coblentz CL, Babcook CJ, Alton D, Riley BJ, Norman G. Observer variation in detecting the radiologic features associated with bronchiolitis. Invest Radiol 1991; 26: 115-118.
26. Kleinbaum DG, Kupper LL, Müller R. Applied regression analysis and other multivariate methods. Boston, MA, Kent, 1988.
27. Cherniack RM, Colby TV, Flint A, et al. and the BAL Co-operative Group Steering Committee. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991; 144: 892-900.
28. Wright PH, Heard BE, Steel SJ, Turner-Warwick M. Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features. Br J Dis Chest 1981; 75: 61-70.
29. Haslam PL, Turton CWG, Heard B, et al. Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax 1980; 35: 9-18.
30. Wells AU, Lorimer S, Majumdar S, et al. Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium. Eur Respir J 1995; 8: 266-271.
31. Wells AU, Cullinan P, Hansell DM, et al. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1994; 149: 1583-1590.